Oxidative Medicine and Cellular Longevity / 2018 / Article / Tab 6

Research Article

Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke

Table 6

Effect of resveratrol on HbA1c.

EvaluationHbA1c (%)
Resveratrol 100 mg groupResveratrol 200 mg groupControl group
M ± SDESM ± SDESM ± SDES

Initial7.13 ± 1.517.15 ± 1.507.10 ± 1.47
At 6 months6.72 ± 1.400.276.66 ± 1.410.337.09 ± 1.430.01
At 12 months6.61 ± 1.380.086.55 ± 1.400.087.05 ± 1.460.03

Values are represented as mean ± SD ( diabetic patients in the resveratrol 100 mg group; diabetic patients in the resveratrol 200 mg group; and diabetic patients in the control group).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.